During year 3, clinical studies within the TransBioLine project are progressing in the enrolment of patients to move forward in the identification of novel biomarkers that reliably indicate specific organ injury during drug development. Status [...]
enrolling: trial is running, patient recruitment is underway approved: ethical approval has been received, patients not yet being recruited submitted: study awaiting [...]
The TransBioLine WP4 (Biomarkers of vascular injury) Letter of Intent was accepted by the FDA on February 2020 and the team is in preparation to discuss the FDA recommendations to [...]
